4
Changes in Ownership
Outlook Therapeutics, Inc. Filed Acc 0001209191-22-053354
Director bought 33,343 shares at an average $1.29 ($42,940)
From the SEC's structured data for this filing
Trades in this filing
Haddadin Yezan Munther · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-10-06 | Purchase : show line 1 in the form | +29,743 | $1.29 | $38,368 | 59,743 | D |
| 2022-10-07 | Purchase : show line 2 in the form | +3,600 | $1.27 | $4,572 | 63,343 | D |
| Open-market purchases · 33,343 sh · avg $1.29 · $42,940 | ||||||
Loading xslF345X03/doc4.xml…